[Federal Register: October 1, 2003 (Volume 68, Number 190)]
[Notices]               
[Page 56641-56642]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01oc03-84]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, ZRG1 SSS8 03 SAT Member Conflict.
    Date: October 8, 2003.
    Time: 3 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Paul Parakkal, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5122, MSC 7854, Bethesda, MD 20892, 301-435-1176, parakkap@csr.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.


[[Page 56642]]


    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Psychiatric Genetics.
    Date: October 14, 2003.
    Time: 2 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, Room 
2208, Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Camilla E. Day, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 2212, MSC 7890, Bethesda, MD 20892, (301) 435-1037, dayc@csr.nih.gov.

    Name of Committee: Infectious Diseases and Microbiology 
Integrated Review Group Bacteriology and Mycology Subcommittee 2.
    Date: October 15-16, 2003.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: St. Gregory Hotel, 2033 M Street, NW., Washington, DC 
20036.
    Contact Person: Melody Mills, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, MSC 7808, Room 4190, Bethesda, MD 
20892, 301-435-0903.

    Name of Committee: Brain Disorders and Clinical Neuroscience 
Integrated Review Group Clinical Neuroscience and Disease Study 
Section.
    Date: October 20-21, 2003.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Chevy Chase, 5520 Wisconsin Avenue, Chevy 
Chase, MD 20815.
    Contact Person: David M. Armstrong, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD 20892, (301) 435-1253, armstrda@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel T-Cell Immunology.
    Date: October 21, 2003.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Calbert A. Laing, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4210, MSC 7812, Bethesda, MD 20892, 301-435-1221, laingc@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel Special R01 Grant Review.
    Date: October 21, 2003.
    Time: 1:30 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Raya Mandler, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5217, MSC 7840, Bethesda, MD 
20892, (301) 402-8228.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel Trudi McFarland's Member Conflicts.
    Date: October 21, 2003.
    Time: 4 p.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Karin F. Helmers, PhD, Scientific Review 
Administrator, Center for Scientific Review/SNEM IRG, 6701 Rockledge 
Drive, Room 3166, MSC 7770, Bethesda, MD 20892, 301-435-1017, helmersk@csr.nih.gov.

    Name of Committee: Brain Disorders and Clinical Neuroscience 
Integrated Review Group Neural Basis of Psychopathology, Addictions 
and Sleep Disorders Study Section.
    Date: October 23-24, 2003.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Governor's House Hotel, 1615 Rhode Island Avenue, NW., 
Washington, DC 20036.
    Contact Person: Jay Cinque, MS, Scientific Review Administrator, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5186, MSC 7846, Bethesda, MD 20892, 301-435-1252, cinquej@csr.nih.gov.

    Name of Committee: Risk, Prevention and Health Behavior 
Integrated Review Group Behavioral Medicine, Interventions and 
Outcomes Study Section.
    Date: October 23-24, 2003.
    Time: 8:30 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Baltimore Marriott Waterfront Hotel, 700 Aliceanna 
Street, Baltimore, MD 21202.
    Contact Person: Lee S. Mann, MA, JD, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3186, MSC 7848, Bethesda, MD 20892, (301) 435-0677, mannl@mail.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel Genetics and Psychiatric Diseases.
    Date: October 24, 2003.
    Time: 12 p.m. to 1 p.m.
    Agenda: To review and evaluate grant applications.
    Place: One Washington Circle Hotel, One Washington Circle, 
Washington, DC 20037.
    Contact Person: Cheryl M. Corsaro, PhD, Genetic Sciences IRG, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 2204, MSC 7890, Bethesda, MD 20892, (301) 435-1045, corsaroc@csr.nih.gov.

    Name of Committee: Oncological Sciences Integrated Review Group 
Tumor Cell Biology Study Section.
    Date: October 27-28, 2003.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Latham Hotel, 3000 M Street, NW., Washington, DC 20007.
    Contact Person: Angela Y. Ng, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6200, MSC 7804, (For courier 
delivery, use MD 20817), Bethesda, MD 20892, 301-435-1715, nga@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel B-Cell Immunology.
    Date: October 29, 2003.
    Time: 1 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Calbert A. Laing, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4210, MSC 7812, Bethesda, MD 20892, 301-435-1221, laingc@csr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research 93.306, 93.333, 
93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)


    Dated: September 24, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-24819 Filed 9-30-03; 8:45am]

BILLING CODE 4140-01-M